GroundForce backs Epicutis, a science-led skincare brand growing revenue at 100% a year
What's the deal? GroundForce CapitalDealroom has a profile for this one. Try Dealroom → has made a growth equity investment in Epicutis, a skincare brand built around patented, biotechnology-derived actives. As part of the deal, announced in July 2026, GroundForce will join Epicutis's board of directors.
What does the company do? Epicutis, legally Signum Dermalogix, develops clean, minimalist formulations based on proprietary, patent-protected actives including TSC, DSD and HYVIA. The brand sells exclusively through the professional channel — medspas, dermatology practices, and luxury spas — with over 4,100 active professional accounts nationwide.
The company traces its roots to more than 20 years of bioscience research affiliated with Princeton University through Signum BiosciencesDealroom has a profile for this one. Try Dealroom →.
The numbers: Epicutis has grown revenue at nearly a 100% compound annual growth rate over the two years to 2026, driven by rising adoption among skincare professionals. It expects to sustain that trajectory as consumers increasingly seek professional product recommendations.
What's the money for? The investment supports Epicutis's next phase of growth in the professional dermocosmetics channel. Funds will go toward building brand awareness, product innovation, and expanding its discovery pipeline.
What did they say? "Epicutis has built something rare in skincare: a genuinely differentiated scientific platform paired with the sales execution to bring it to market at scale," said Dan Gluck, co-founder and co-managing partner of GroundForce Capital.
Chief executive officer and co-founder Maxwell Stock said the partnership lets Epicutis "move faster on everything that matters: the discovery pipeline behind the brand, the professional channel we intend to lead, and the standard of proof we hold ourselves to." DC AdvisoryDealroom has a profile for this one. Try Dealroom → served as exclusive financial advisor to Epicutis.
The signal: GroundForce, whose portfolio includes brands such as Bobbie and Liquid Death, is betting on the professional skincare channel as a growth engine. The wager reflects a broader shift, as shoppers increasingly turn to dermatologists and estheticians — not shelves — for what to buy.
Read more: TMCnet
